Last reviewed · How we verify
NCT05617118: BvsB
BTA vs Baclofen for Pelvic Myofascial Pain Syndrome
trial testing Baclofen 10mg in Chronic Pain in 52 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Saint Petersburg State University, Russia |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 52 |
| Start date | 1 December 2022 |
| Primary completion | 31 December 2023 |
| Estimated completion | 1 May 2024 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- Baclofen 10mg — full drug profile →
- Botulinum toxin type A (BOTULINUM TOXIN TYPE A) — full drug profile →
Conditions studied
- Chronic Pain — all drugs for Chronic Pain →
- Chronic Pelvic Pain Syndrome — all drugs for Chronic Pelvic Pain Syndrome →
- Myofascial Pain Syndrome — all drugs for Myofascial Pain Syndrome →
- Myofascial Trigger Point Pain — all drugs for Myofascial Trigger Point Pain →
Sponsor
Saint Petersburg State University, Russia
Who can join
Adults 18 to 75, any sex, with Chronic Pain or Chronic Pelvic Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to test the hypothesis that oral taking of baclofen in therapeutic dosage for 60 days is equally effective as injection of botulinum toxin type "A" in the area of trigger points of the pelvic muscles.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05617118
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Baclofen 10mg
Trials testing the same drug.
- NCT04251819 — Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers · Phase 2, PHASE3 · terminated
- NCT03720717 — Baclofen as a Perioperative Analgesic Adjuvant · Phase 4 · terminated
Other recruiting trials for Chronic Pain
Currently open trials in the same condition.
- NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
- NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
- NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
- NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
- NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
Other Saint Petersburg State University, Russia trials
Trials by the same sponsor.
- NCT07116343 — Intrapleural Ropivacaine Infusion in Cardiac Surgery · Phase 4 · recruiting
- NCT07185334 — Single-Stage Prepectoral Placement of Textured Implants Using a Polyester Mesh Endoprostheses With Fluoropolymer Coating · NA · active not recruiting
- NCT07106112 — Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy · NA · recruiting
- NCT06654401 — Electrical Cardioversion As a Predictor in Postoperative Preservation of Sinus Rhythm · NA · recruiting
- NCT06626711 — Effect of Propofol and Sevoflurane Anesthesia on HSP70 Expression in Tumor Cells · EARLY_PHASE1 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05617118 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Saint Petersburg State University, Russia
- Last refreshed: 11 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05617118.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing